Azelastine and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azelastine (azelastine hydrochloride) and Mesalamine (mesalamine). Common drug interactions include injection site pruritus among females and clostridium difficile colitis among males.

The phase IV clinical study analyzes what interactions people have when they take Azelastine and Mesalamine. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,400 Azelastine users. Check the latest studies of Azelastine.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.



On Aug, 06, 2026

72 people who take Azelastine and Mesalamine together, and have interactions are studied.

Azelastine and Mesalamine drug interactions.

What are the common drug interactions of Azelastine and Mesalamine, by gender? *:

female:

  1. Injection site pruritus (severe itching at injection site)
  2. Injection site rash
  3. Injection site swelling
  4. Injection site urticaria (rash of round, red welts on the skin at injection site)
  5. Intervertebral disc protrusion (spinal disc protrusion)
  6. Intestinal ulcer
  7. Anxiety
  8. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  9. Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
  10. Respiratory distress (difficulty in breathing)

male:

  1. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  2. Pneumonia
  3. Accidental exposure
  4. Back pain
  5. Blood disorder
  6. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Dizziness
  9. Dyspnoea (difficult or laboured respiration)
  10. Ear infection

What are the common drug interactions of Azelastine and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug hypersensitivity
  2. Infusion related reaction
  3. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Drug ineffective
  6. Eosinophilic pneumonia (eosinophil accumulates in the lung)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Stent placement

20-29:

  1. Abdominal pain upper
  2. Administration site pain
  3. Arthralgia (joint pain)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Device related infection
  6. Fatigue (feeling of tiredness)
  7. Impaired gastric emptying
  8. Nausea (feeling of having an urge to vomit)
  9. Post-traumatic stress disorder
  10. Sleep disorder

30-39:

  1. Anxiety
  2. Heart rate decreased
  3. Hypotension (abnormally low blood pressure)
  4. Injection site bruising
  5. Injection site pruritus (severe itching at injection site)
  6. Injection site rash
  7. Injection site urticaria (rash of round, red welts on the skin at injection site)
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Precancerous skin lesion
  10. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

40-49:

  1. Pain
  2. Abdominal abscess (collection of pus in abdomen)
  3. Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
  4. Back pain
  5. Chronic kidney disease
  6. Headache (pain in head)
  7. Injection site pain
  8. Intervertebral disc protrusion (spinal disc protrusion)
  9. Nausea (feeling of having an urge to vomit)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Drug ineffective
  3. Septic shock (shock due to blood infection)
  4. Arthralgia (joint pain)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Fatigue (feeling of tiredness)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Pyrexia (fever)

60+:

  1. Influenza
  2. Sedation
  3. Dyspnoea (difficult or laboured respiration)
  4. Gallbladder operation
  5. Injection site haemorrhage (bleeding from injection site)
  6. Pruritus (severe itching of the skin)
  7. Scar
  8. Skin irritation
  9. Urinary tract infection
  10. Anaemia (lack of blood)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 26.39%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 18 people, 25.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 13.89%
  4. High Blood Pressure: 8 people, 11.11%
  5. Stress And Anxiety: 8 people, 11.11%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 9.72%
  7. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 6.94%
  8. Multiple Allergies (allergy to multiple agents): 5 people, 6.94%
  9. Pneumonia: 5 people, 6.94%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 6.94%

* Approximation only. Some reports may have incomplete information.

Do you take Azelastine and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azelastine and Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azelastine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azelastine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mesalamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on azelastine hydrochloride and mesalamine (the active ingredients of Azelastine and Mesalamine, respectively), and Azelastine and Mesalamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: